XML 21 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities:    
Net income $ 3,966 $ 3,167
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization 1,579 576
Amortization of debt discount 18 10
Bad debt expense 105 61
Share-based compensation 1,575 421
Inventory reserve 77 52
Provision (benefit) for deferred income taxes 681 (3)
Gain on sale of assets 15
(Increase) decrease in operating assets:    
Accounts receivable 3,773 (2,390)
Inventories (1,884) (838)
Vendor deposits 826 1,356
Costs in excess of billings on uncompleted contracts (926) (86)
Other assets (533) 1,055
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses (4,320) 2,040
Accrued employee expenses 2,702 335
Customer deposits 5,593 (1,439)
Billings in excess of costs on uncompleted contracts (1,887) (1,742)
Net cash provided by operating activities 11,345 2,590
Investing activities:    
Capital expenditures (829) (237)
Cash paid for acquisitions, net of cash acquired (13,352) (14,708)
Net cash used in investing activities (14,181) (14,945)
Financing activities:    
Dividends paid (1,403) (1,040)
Proceeds from borrowings 71,628 25,934
Debt repayments (66,079) (21,666)
Payment of debt issuance costs (88)
Proceeds from issuance of common shares to related party 6,000
Purchase of shares (707)
Net cash provided by financing activities 3,439 9,140
Net increase (decrease) in cash and cash equivalents 603 (3,215)
Cash and cash equivalents at beginning of year 727 3,942
Cash and cash equivalents at end of year 1,330 727
Supplemental information:    
Cash paid for interest 499 152
Cash paid for income taxes $ 1,223 $ 1,843
Supplemental disclosure of non-cash financing activities    
Common stock issued for acquisitions 21,376 18,587